Literature DB >> 29980579

Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction.

Duan Liu1, Sisi Qin1, Balmiki Ray1, Krishna R Kalari1, Liewei Wang1, Richard M Weinshilboum2.   

Abstract

CYP1A1 expression can be upregulated by the ligand-activated aryl hydrocarbon receptor (AHR). Based on prior observations with estrogen receptors and estrogen response elements, we tested the hypothesis that single-nucleotide polymorphisms (SNPs) mapping hundreds of base pairs (bp) from xenobiotic response elements (XREs) might influence AHR binding and subsequent gene expression. Specifically, we analyzed DNA sequences 5 kb upstream and downstream of the CYP1A1 gene for putative XREs. SNPs located ±500 bp of these putative XREs were studied using a genomic data-rich human lymphoblastoid cell line (LCL) model system. CYP1A1 mRNA levels were determined after treatment with varying concentrations of 3-methylcholanthrene (3MC). The rs2470893 (-1694G>A) SNP, located 196 bp from an XRE in the CYP1A1 promoter, was associated with 2-fold variation in AHR-XRE binding in a SNP-dependent fashion. LCLs with the AA genotype displayed significantly higher AHR-XRE binding and CYP1A1 mRNA expression after 3MC treatment than did those with the GG genotype. Electrophoretic mobility shift assay (EMSA) showed that oligonucleotides with the AA genotype displayed higher LCL nuclear extract binding after 3MC treatment than did those with the GG genotype, and mass spectrometric analysis of EMSA protein-DNA complex bands identified three candidate proteins, two of which were co-immunoprecipitated with AHR. In conclusion, we have demonstrated that the rs2470893 SNP, which maps 196 bp from a CYP1A1 promoter XRE, is associated with variations in 3MC-dependent AHR binding and CYP1A1 expression. Similar "distant SNP effects" on AHR binding to an XRE motif and subsequent gene expression might occur for additional AHR-regulated genes.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29980579      PMCID: PMC6090174          DOI: 10.1124/dmd.118.082164

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  50 in total

1.  Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene.

Authors:  K Kawajiri; K Nakachi; K Imai; A Yoshii; N Shinoda; J Watanabe
Journal:  FEBS Lett       Date:  1990-04-09       Impact factor: 4.124

2.  Chromatin immunoprecipitation (ChIP).

Authors:  Michael F Carey; Craig L Peterson; Stephen T Smale
Journal:  Cold Spring Harb Protoc       Date:  2009-09

3.  The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis.

Authors:  M S Denison; J M Fisher; J P Whitlock
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

Review 4.  The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.

Authors:  André Guillouzo; Anne Corlu; Caroline Aninat; Denise Glaise; Fabrice Morel; Christiane Guguen-Guillouzo
Journal:  Chem Biol Interact       Date:  2006-12-16       Impact factor: 5.192

Review 5.  Genetic polymorphism of cytochromes P450 1A1, 2D6 and 2E1: regulation and toxicological significance.

Authors:  A Rannug; A K Alexandrie; I Persson; M Ingelman-Sundberg
Journal:  J Occup Environ Med       Date:  1995-01       Impact factor: 2.162

6.  Caffeine induces CYP1A2 expression in rat hepatocytes but not in human hepatocytes.

Authors:  David Vaynshteyn; Hyunyoung Jeong
Journal:  Drug Metab Lett       Date:  2012-06-01

7.  The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population.

Authors:  C Kiyohara; Y Nakanishi; S Inutsuka; K Takayama; N Hara; A Motohiro; K Tanaka; S Kono; T Hirohata
Journal:  Pharmacogenetics       Date:  1998-08

8.  Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention.

Authors:  James N Ingle; Mohan Liu; D Lawrence Wickerham; Daniel J Schaid; Liewei Wang; Taisei Mushiroda; Michiaki Kubo; Joseph P Costantino; Victor G Vogel; Soonmyung Paik; Matthew P Goetz; Matthew M Ames; Gregory D Jenkins; Anthony Batzler; Erin E Carlson; David A Flockhart; Norman Wolmark; Yusuke Nakamura; Richard M Weinshilboum
Journal:  Cancer Discov       Date:  2013-06-13       Impact factor: 39.397

9.  Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior.

Authors:  Marilyn C Cornelis; Tim Kacprowski; Cristina Menni; Stefan Gustafsson; Edward Pivin; Jerzy Adamski; Anna Artati; Chin B Eap; Georg Ehret; Nele Friedrich; Andrea Ganna; Idris Guessous; Georg Homuth; Lars Lind; Patrik K Magnusson; Massimo Mangino; Nancy L Pedersen; Maik Pietzner; Karsten Suhre; Henry Völzke; Murielle Bochud; Tim D Spector; Hans J Grabe; Erik Ingelsson
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

10.  Structure of RCC1 chromatin factor bound to the nucleosome core particle.

Authors:  Ravindra D Makde; Joseph R England; Hemant P Yennawar; Song Tan
Journal:  Nature       Date:  2010-08-25       Impact factor: 49.962

View more
  4 in total

1.  TCF7L2 lncRNA: a link between bipolar disorder and body mass index through glucocorticoid signaling.

Authors:  Duan Liu; Thanh Thanh Le Nguyen; Huanyao Gao; Huaizhi Huang; Daniel C Kim; Brenna Sharp; Zhenqing Ye; Jeong-Heon Lee; Brandon J Coombes; Tamas Ordog; Liewei Wang; Joanna M Biernacka; Mark A Frye; Richard M Weinshilboum
Journal:  Mol Psychiatry       Date:  2021-09-17       Impact factor: 13.437

Review 2.  Current Therapeutic Landscape and Safety Roadmap for Targeting the Aryl Hydrocarbon Receptor in Inflammatory Gastrointestinal Indications.

Authors:  Samantha C Faber; Tejas S Lahoti; Ewan R Taylor; Lauren Lewis; Jessica M Sapiro; Vicencia Toledo Sales; Yvonne P Dragan; Brandon D Jeffy
Journal:  Cells       Date:  2022-05-21       Impact factor: 7.666

Review 3.  The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases.

Authors:  Drew R Neavin; Duan Liu; Balmiki Ray; Richard M Weinshilboum
Journal:  Int J Mol Sci       Date:  2018-12-03       Impact factor: 5.923

4.  Single Nucleotide Polymorphisms at a Distance from Aryl Hydrocarbon Receptor (AHR) Binding Sites Influence AHR Ligand-Dependent Gene Expression.

Authors:  Drew R Neavin; Jeong-Heon Lee; Duan Liu; Zhenqing Ye; Hu Li; Liewei Wang; Tamas Ordog; Richard M Weinshilboum
Journal:  Drug Metab Dispos       Date:  2019-07-10       Impact factor: 3.922

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.